# Terminalia bellirica Extract Attenuates Fat Accumulation Through Modulation of Obesity-Related Dysmetabolism in 3T3-L1 Adipocytes and High-Fat Diet-Induced Obese Mice

**Authors:** Hyunyoung Choi, Yeonhwa Lee, Seong-Hoo Park, Jeongjin Park, Kun Hee Park, Kwang-Soo Baek, Jinhak Kim, Hyunmook Jung, Jaehwan Kim, Woojin Jun

PMC · DOI: 10.3390/ijms27042014 · International Journal of Molecular Sciences · 2026-02-20

## TL;DR

This study shows that Terminalia bellirica extract reduces fat accumulation in cells and mice by altering metabolic pathways linked to obesity.

## Contribution

The study provides new evidence that Terminalia bellirica extract has anti-obesity effects in both cell and animal models.

## Key findings

- TBE inhibited lipid accumulation and downregulated genes involved in fat formation and lipid production in 3T3-L1 cells.
- TBE reduced body weight, fat mass, and fat cell size in high-fat diet-induced obese mice.
- TBE upregulated genes related to fat breakdown and energy metabolism in both in vitro and in vivo models.

## Abstract

Terminalia bellirica extract (TBE) has long been utilized in Ayurvedic medicine across Indian and surrounding regions for diverse therapeutic applications. Despite its traditional prominence, systematic investigations addressing the anti-obesity efficacy and underlying mechanisms remain limited. In this study, we evaluated the anti-obesity potential of TBE using both 3T3-L1 adipocyte and high-fat diet (HFD)-induced mice model. In vitro studies using 3T3-L1 adipocytes demonstrated that TBE significantly inhibited lipid accumulation and downregulated key genes involved in adipogenesis and lipogenesis, while upregulating genes promoted lipolysis and energy metabolism. To validate these cellular effects in a physiological context, mice were randomly assigned to six groups: normal control (NC), HFD-induced obese (C), HFD with metformin (100 mg/kg b.w., PC), and HFD with TBE at 50, 100, and 200 mg/kg b.w. Consistent with the in vitro findings, TBE supplementation significantly reduced body weight gain, adipose tissue mass, and adipocyte size in HFD-induced obese mice. Taken together, these results indicate that TBE exerts anti-obesity effects through modulation of adipose tissue metabolic pathways, highlighting its therapeutic potential for obesity management.

## Linked entities

- **Chemicals:** metformin (PubChem CID 4091)
- **Diseases:** obesity (MONDO:0011122)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Glul (glutamate-ammonia ligase) [NCBI Gene 14645] {aka GS, Glns}, Acc (anterior capsular cataract) [NCBI Gene 104371], Ucp1 (uncoupling protein 1 (mitochondrial, proton carrier)) [NCBI Gene 22227] {aka Slc25a7, Ucp}, Lipe (lipase E, hormone sensitive type) [NCBI Gene 16890] {aka 4933403G17Rik, HSL, REH}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Pde3b (phosphodiesterase 3B, cGMP-inhibited) [NCBI Gene 18576] {aka 9830102A01Rik}, Adipoq (adiponectin, C1Q and collagen domain containing) [NCBI Gene 11450] {aka 30kDa, APN, Acdc, Acrp30, Ad, Adid}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Lpl (lipoprotein lipase) [NCBI Gene 16956], Lep (leptin) [NCBI Gene 16846] {aka ob, obese}, Fasn (fatty acid synthase) [NCBI Gene 14104] {aka A630082H08Rik, FAS}, Apoc4 (apolipoprotein C-IV) [NCBI Gene 11425] {aka Acl, apo-CIV, apoC-IV}, Srebf1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 20787] {aka ADD1, SREBP1, bHLHd1}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}, Cpt1a (carnitine palmitoyltransferase 1a, liver) [NCBI Gene 12894] {aka C730027G07, CPTI, Cpt1}, Cebpa (CCAAT/enhancer binding protein alpha) [NCBI Gene 12606] {aka C/ebpalpha, CBF-A, Cebp}, Pnpla2 (patatin-like phospholipase domain containing 2) [NCBI Gene 66853] {aka 0610039C21Rik, 1110001C14Rik, Atgl, TTS-2.2}, Fabp4 (fatty acid binding protein 4, adipocyte) [NCBI Gene 11770] {aka 422/aP2, AFABP, ALBP, ALBP/Ap2, Ap2, Lbpl}
- **Diseases:** inflammation (MESH:D007249), injury to (MESH:D014947), coronary heart disease (MESH:D003327), hypertension (MESH:D006973), diabetes (MESH:D003920), weight loss (MESH:D015431), Obese (MESH:D009765), Weight gain (MESH:D015430), type 2 diabetes mellitus (MESH:D003924), respiratory disorders (MESH:D012131), constipation (MESH:D003248), diarrhea (MESH:D003967), osteoarthritis (MESH:D010003), impaired energy metabolism (MESH:D008659)
- **Chemicals:** H&amp;E (MESH:D006371), methanol (MESH:D000432), paraffin (MESH:D010232), DMEM (-), Fat (MESH:D005223), gallic acid (MESH:D005707), hematoxylin (MESH:D006416), Glycerol (MESH:D005990), penicillin (MESH:D010406), proton (MESH:D011522), 3-isobutyl-1-methylxanthine (MESH:D015056), dexamethasone (MESH:D003907), fatty acid (MESH:D005227), PC (MESH:C053518), streptomycin (MESH:D013307), Triton X-100 (MESH:D017830), TG (MESH:D014280), L-glutamine (MESH:D005973), metformin (MESH:D008687), CO2 (MESH:D002245), water (MESH:D014867), ATP (MESH:D000255), AMP (MESH:D000249), chebulagic acid (MESH:C076178), Oil Red O (MESH:C011049), acetyl CoA (MESH:D000105), Lipid (MESH:D008055), FFA (MESH:D005230), chloroform (MESH:D002725), HCl (MESH:D006851), ellagic acid (MESH:D004610), isopropanol (MESH:D019840), eosin (MESH:D004801), cholesterol (MESH:D002784), DMSO (MESH:D004121), formaldehyde (MESH:D005557), ethanol (MESH:D000431)
- **Species:** Terminalia bellirica (bahera, species) [taxon 155021], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** D10012G, C for 4-8
- **Cell lines:** 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940958/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940958/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940958/full.md

---
Source: https://tomesphere.com/paper/PMC12940958